ZS Pharma Lands $2M

Fort Worth-based ZS Pharma, a firm which is developing treatments for patients with liver or kidney disease, has raised $2M in funding from the Texas Emerging Technology Fund, according to the ETF Monday. ZS Pharma, which was originally based in Indiana, relocated to Fort Worth a little over a year ago to join the TECH Fort Worth not-for-profit business incubator. ZS Pharma's technology treats hyperkalemia,an abnormal concentration of potassium in the blood that can cause life threatening issues for patients with liver or kidney disease. ZS Pharma said the funding will go towards activities to advance commercialization of its technology. More information »